Influence of Hypovolemia on the Pharmacokinetics and Electroencephalographic Effect of &ggr;-Hydroxybutyrate in the Rat

Background Hypovolemia alters the effect of propofol in the rat by influencing the pharmacokinetics and the end organ sensitivity. We now studied the effect of hypovolemia on the anesthetic &ggr;-hydroxybutyrate (GHB) because in contrast with propofol it increases blood pressure. Methods Thirty-two rats were randomly assigned to undergo moderate hypovolemia or a control procedure. Each rat received either an infusion of sodium–GHB (390 mg · kg−1 · 5 min−1) or the same volume of an equimolar solution of sodium chloride (6.9%). Plasma samples were taken for GHB assay (high-performance liquid chromatography) and the electroencephalography and blood pressure values were recorded. A two-compartment model with Michaelis–Menten elimination was fitted to the concentration-time data and a sigmoid Emax model to the electroencephalographic effect versus effect site concentration curve allowing the study of the end organ sensitivity. Results Plasma concentration–time curves and the total volume of distribution in hypovolemic and normovolemic rats were comparable with only small but significant differences in central volume of distribution and the intercompartmental clearance. There was no significant difference either in the distribution from the plasma to the brain (ke0) or in the end organ sensitivity (EC50 = 335 ± 76 &mgr;g/ml in control vs. 341 ± 89 &mgr;g/ml in hypovolemic rats). GHB temporarily increased mean arterial pressure in both groups, which cannot be explained by the sodium salt alone. Conclusions Hypovolemia does not influence the overall concentration–time curve of GHB and induces no changes in the electroencephalographic effect of GHB in the rat. This difference with propofol may be due to the fact that it increases blood pressure but also due to its different pharmacokinetic properties.

[1]  Tim Morris,et al.  Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.

[2]  G. Gessa,et al.  Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers , 2004, European Journal of Clinical Pharmacology.

[3]  J. Feely,et al.  Profound reduction in morphine clearance and liver blood flow in shock , 2004, Intensive Care Medicine.

[4]  P. Boon,et al.  Relationship between gamma‐hydroxybutyrate plasma concentrations and its electroencephalographic effects in the rat , 2001, The Journal of pharmacy and pharmacology.

[5]  G. Gessa,et al.  Selective breeding of two rat lines differing in sensitivity to GHB and baclofen , 2001, Brain Research.

[6]  A. Biedler,et al.  [Gamma-hydroxybutyric acid-ethanolamide (LK 544). The suitability of LK 544 for sedation of patients in intensive care in comparison with midazolam]. , 2001, Der Anaesthesist.

[7]  J. Benak,et al.  Gammahydroxybuttersäure-Ethanolamid (LK 544) Die Eignung von LK 544 zur Sedierung von Intensivpatienten im Vergleich mit Midazolam , 2001, Der Anaesthesist.

[8]  Y. Vander Heyden,et al.  Development and validation of a high-performance liquid chromatographic method for the determination of gamma-hydroxybutyric acid in rat plasma. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[9]  Steven Edward Kern,et al.  Influence of Hemorrhagic Shock on Remifentanil: A Pharmacokinetic and Pharmacodynamic Analysis , 2001, Anesthesiology.

[10]  P. Boon,et al.  Influence of Hypovolemia on the Pharmacokinetics and the Electroencephalographic Effect of Propofol in the Rat , 2000, Anesthesiology.

[11]  C. Bol,et al.  Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat. , 2000, The Journal of pharmacology and experimental therapeutics.

[12]  N. Swerdlow,et al.  Toward Understanding the Biology of a Complex Phenotype: Rat Strain and Substrain Differences in the Sensorimotor Gating-Disruptive Effects of Dopamine Agonists , 2000, The Journal of Neuroscience.

[13]  C. Niemann,et al.  Modifications of blood volume alter the disposition of markers of blood volume, extracellular fluid, and total body water. , 1999, The Journal of pharmacology and experimental therapeutics.

[14]  P. Boon,et al.  Influence of hypovolemia on the pharmacokinetics and the electroencephalographic effect of etomidate in the rat. , 1999, The Journal of pharmacology and experimental therapeutics.

[15]  S. McJames,et al.  Fentanyl pharmacokinetics in hemorrhagic shock: a porcine model. , 1999, Anesthesiology.

[16]  W. Buylaert,et al.  The influence of hemorrhagic shock on the pharmacokinetics and the analgesic effect of morphine in the rat , 1998, Fundamental & clinical pharmacology.

[17]  R. Larsen,et al.  Total intravenous anaesthesia with gamma-hydroxybutyrate (GHB) and sufentanil in patients undergoing coronary artery bypass graft surgery: a comparison in patients with unimpaired and impaired left ventricular function. , 1998, European journal of anaesthesiology.

[18]  Russell D. Wada,et al.  Application of Physiologic Models to Predict the Influence of Changes in Body Composition and Blood Flows on the Pharmacokinetics of Fentanyl and Alfentanil in Patients , 1998, Anesthesiology.

[19]  M Danhof,et al.  Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in rats. , 1998, The Journal of pharmacology and experimental therapeutics.

[20]  M Danhof,et al.  Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat. , 1997, The Journal of pharmacology and experimental therapeutics.

[21]  T. Fabian,et al.  Efficacy of hypertonic 7.5% saline and 6% dextran-70 in treating trauma: a meta-analysis of controlled clinical studies. , 1997, Surgery.

[22]  F. Mertzlufft,et al.  Gamma-Hydroxy-Buttersäure - Hat sie einen Stellenwert in Anästhesie und Intensivmedizin? , 1995 .

[23]  M. Avram,et al.  A recirculatory pharmacokinetic model describing the circulatory mixing, tissue distribution and elimination of antipyrine in dogs. , 1994, The Journal of pharmacology and experimental therapeutics.

[24]  E Kochs,et al.  The effects of propofol on cerebral and spinal cord blood flow in rats. , 1993, Anesthesia and analgesia.

[25]  M. Avram,et al.  The relationship between alfentanil distribution kinetics and cardiac output , 1992, Clinical pharmacology and therapeutics.

[26]  H. Kalant,et al.  Tolerance to ethanol and cross-tolerance to pentobarbital and barbital in four rat strains , 1991, Pharmacology Biochemistry and Behavior.

[27]  P. Safar,et al.  Dying pattern in volume-controlled hemorrhagic shock in awake rats. , 1991, Resuscitation.

[28]  G Levy,et al.  Kinetics of drug action in disease states. XXV. Effect of experimental hypovolemia on the pharmacodynamics and pharmacokinetics of desmethyldiazepam. , 1988, The Journal of pharmacology and experimental therapeutics.

[29]  G Levy,et al.  Kinetics of drug action in disease states. XXIII: Effect of acute hypovolemia on the pharmacodynamics of phenobarbital in rats. , 1988, Journal of pharmaceutical sciences.

[30]  M. Danhof,et al.  Pharmacokinetic-pharmacodynamic modeling of CNS drug effects: an overview. , 1988, Pharmacology & therapeutics.

[31]  D. Greenblatt,et al.  Midazolam Pharmacodynamics and Pharmacokinetics during Acute Hypovolemia , 1985, Anesthesiology.

[32]  N. Benowitz,et al.  Pharmacokinetic and Pharmacodynamic Considerations in Drug Therapy of Cardiac Emergencies , 1984, Clinical pharmacokinetics.

[33]  B. Johansson,et al.  Cerebrovascular permeability and cerebral blood flow in hypertension induced by gammahydroxybutyric acid , 1982, Acta neurologica Scandinavica.

[34]  L B Sheiner,et al.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. , 1980, Clinical pharmacology and therapeutics.

[35]  G. Harrison Death attributable to anaesthesia. A 10-year survey (1967--1976). , 1978, British journal of anaesthesia.

[36]  J. Watkins,et al.  Acute tolerance to barbiturate in the rat. , 1976, European journal of pharmacology.

[37]  H. Akaike A new look at the statistical model identification , 1974 .

[38]  R P Forsyth,et al.  Lidocaine disposition kinetics in monkey and man; II. Effects of hemorrhage and sympathomimetic drug administration , 1974, Clinical pharmacology and therapeutics.

[39]  P. Spano,et al.  Interaction of sodium γ-hydroxybutyrate with catecholamines in rat heart and adipose tissue , 1970 .